6:12 PM
Dec 10, 2012
 |  BC Extra  |  Top Story

Amgen to acquire deCode genetics

Amgen Inc. (NASDAQ:AMGN) will acquire genomics company deCode genetics ehf (Reykjavik, Iceland) for $415 million in cash. The deal, which has been approved by Amgen's board, is expected to close by year...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >